Electron Microscopy in End Stage Renal Disease: A Case of Fabry's Disease

REFERENCES

• Faraggiana T, Churg J, Grishman E, et al. Light and electron-microscopic histochemistry of Fabry's disease. Am J Pathol. 1981;103:247–262.
   PubMed Web of Science ®Google Scholar
• Germain DP. Fabry's disease (alpha-galactosidase-A deficiency): physiopathology, clinical signs, and genetic aspects. J Soc Biol. 2002;196:161–173.
   PubMedGoogle Scholar
• Clarke J. Narrative review: Fabry disease. Ann Intern Med. 2007;146:425–433.
   PubMed Web of Science ®Google Scholar
• Tondel C, Bostad L, Hirth A, et al. Renal biopsy findings in children and adolescents with Fabry disease and minimal albuminuria. Am J Kid Dis. 2008;51:767–776.
   PubMed Web of Science ®Google Scholar
• Gubler MC, Lenoir G, Grunfeld JP, et al. Early renal changes in hemizygous and heterozygous patients with Fabry's disease. Kidney Int. 1978;13:223–235.
   PubMed Web of Science ®Google Scholar
• Grunfeld JP, Lidove O, Joly D, Barbey F. Renal disease in Fabry patients. J Inherit Metab Dis. 2001;24:71–74.
   PubMed Web of Science ®Google Scholar
• Alroy J, Sabnis S, Kopp J. Renal pathology in Fabry disease. J Am Soc Nephrol. 2002;13:S134–S138.
   Google Scholar
• Tubbs RR, Gephardt GN, McMahon JT, Hall PM, Gifford RW. Cytoplasmic inclusions of Fabry's disease: ultrastructural demonstration of their presence in urine sediment. Arch Pathol Lab Med. 1981;105:361–362.
   PubMed Web of Science ®Google Scholar
• Wenk RE, Bhagavan BS, Francis E. Myelin bodies in urine sediment in hemizygotes with Anderson-Fabry disease. Ultrastruct Pathol. 1983;5:123–127.
   PubMed Web of Science ®Google Scholar
• Inderbitzin D, Avital I, Largiader F, et al. Kidney transplantation improves survival and is indicated in Fabry's disease. Transplant Proc. 2005;37:4211–4214.
   PubMed Web of Science ®Google Scholar
• Shah T, Gill J, Malhotra N, et al. Kidney transplant outcomes in patients with Fabry disease. Transplantation. 2009;87:280–285.
   PubMed Web of Science ®Google Scholar
• Schiffmann R, Kopp JB, Austin H. Enzyme replacement therapy in Fabry disease: a randomized controlled trial. JAMA. 2001;285:2743–2749.
   PubMed Web of Science ®Google Scholar
• Pearson JM, McWilliam LJ, Coyne JD, et al. Value of electron microscopy in diagnosis of renal disease. J Clin Pathol (Lond). 1994;47:126–128.
   PubMed Web of Science ®Google Scholar
• Haas M. A reevaluation of routine electron microscopy in the examination of native renal biopsies. J Am Soc Nephrol. 1997;8:70–76.
   PubMed Web of Science ®Google Scholar
• Wagrowska-Danilewicz M, Danilewicz M. Current position of electron microscopy in the diagnosis of glomerular diseases. Pol J Pathol. 2007;58:87–92.
   PubMedGoogle Scholar
• Spycher MA. Electron microscopy: a method for the diagnosis of inherited metabolic storage diseases. Electron microscopy in diagnosis. Pathol Res Pract. 1980;167:118–135.
   PubMed Web of Science ®Google Scholar
• Herrera GA, Isaac J, Turbat-Herrera EA, et al. Role of electron microscopy in transplant renal pathology. Ultrastruct Pathol. 1997;21:481–498.
   PubMed Web of Science ®Google Scholar
• Ivanyi B, Kemeny E, Szederkenyi E, et al. The value of electron microscopy in the diagnosis of chronic renal allograft rejection. Mod Pathol. 2001;14:1200–1208.
   PubMed Web of Science ®Google Scholar
• Elleder M, Ledvinova J, Vosmik F. An atypical ultrastructural pattern in Fabry's disease: a study on the nature and incidence in 7 cases. Ultrastruct Pathol. 1990;14:467–474.
   PubMed Web of Science ®Google Scholar
• McNamara TE, Goodloe S, Butkus DE. Myeloid bodies in patients without clinical Fabry's disease. Arch Pathol Lab Med. 1980;104:14–16.
   PubMed Web of Science ®Google Scholar
• Woywodt A, Hellweg S, Schwarz A, et al. A wild zebra chase. Nephrol Dial Transplant. 2007;22:3074–3077.
   PubMed Web of Science ®Google Scholar
• Fukushima M, Tsuchiyama Y, Nakato T, et al. A female heterozygous patient with Fabry's disease with renal accumulation of trihexosylceramide detected with a monoclonal antibody. Am J Kidney Dis. 1995;26:952–955.
   PubMed Web of Science ®Google Scholar
• Desnick RJ, Astrin KH, Bishop DF. Fabry disease: molecular genetics of the inherited nephropathy. Adv Nephrol Necker Hosp. 1989;18:113–127.
   PubMedGoogle Scholar
• Ortiz A, Oliveira JP, Waldek S, et al. Nephropathy in males and females with Fabry's disease: cross-sectional description of patients before treatment with enzyme replacement therapy. Nephrol Dial Transplant. 2008;23:1600–1607.
   PubMed Web of Science ®Google Scholar
• Valbuena C, Carvalho E, Bustorff M, et al. Kidney biopsy findings in heterozygous Fabry disease females with early nephropathy. Virchows Arch. 2008;453:329–338.
   PubMed Web of Science ®Google Scholar
• Tosoni A, Nebuloni M, Zerbi P, et al. Ultrastructural study of renal involvement in two females with Anderson-Fabry disease. Ultrastruct Pathol. 2005;29:203–207.
   PubMed Web of Science ®Google Scholar
• Ojo A, Meier-Kriesche HU, Friedman G. Excellent outcome of renal transplantation in patients with Fabry's disease. Transplantation. 2000;69:2337–2339.
   PubMed Web of Science ®Google Scholar
• Friedlaender MM, Kopolovic J, Rubinger D, et al. Renal biopsy in Fabry's disease eight years after successful renal transplantation. Clin Nephrol. 1987;27:206–211.
   PubMed Web of Science ®Google Scholar
• Ramos E. Recurrent diseases in the renal allograft. J Am Soc Nephrol. 1991;2:109–121.
   PubMed Web of Science ®Google Scholar
• Mosnier JF, Degott C, Bedrossian J, et al. Recurrence of Fabry's disease in a renal allograft eleven years after successful renal transplantation. Transplantation. 1991;51:759–762.
   PubMed Web of Science ®Google Scholar
• Gantenbein H, Bruder E, Burger HR, et al. Recurrence of Fabry's disease in a renal allograft 14 years after transplantation. Nephrol Dial Transplant. 1995;10:287–289.
   PubMed Web of Science ®Google Scholar
• Popli S, Molnar ZV, Leehey DJ, et al. Involvement of renal allograft by Fabry's disease. Am J Nephrol. 1987;7:316–318.
   PubMed Web of Science ®Google Scholar
• Grünfeld JP, Le Porrier M, Droz D, et al. Renal transplantation in patients suffering from Fabry's disease: kidney transplantation from a heterozygote subject to a subject without Fabry's disease. Nouv Presse Med. 1975;4:2081–2085.
   PubMedGoogle Scholar
• Eng CM, Guffon N, Wilcox WR, et al. Safety and efficacy of recombinant human α-galactosidase A replacement therapy in Fabry's disease. N Engl J Med. 2001;345:9–16.
   PubMed Web of Science ®Google Scholar
• Breunig F, Wanner C. Update on Fabry disease: kidney involvement, renal progression and enzyme replacement therapy. J Nephrol. 2008;21:32–37.
   PubMed Web of Science ®Google Scholar
• Mignani R, Feriozzi S, Pisani A, et al. Agalsidase therapy in patients with Fabry disease on renal replacement therapy: a nationwide study in Italy. Nephrol Dial Transplant. 2008;23:1628–1635.
   PubMed Web of Science ®Google Scholar
• Cybulla M, Walter KN, Schwarting A, et al. Kidney transplantation in patients with Fabry disease. Transpl Int. 2009;22:475–481.
   PubMedGoogle Scholar
• Thurberg BL, Rennke H, Colvin RB, et al. Globotriaosylceramide accumulation in the Fabry kidney is cleared from multiple cell types after enzyme replacement therapy. Kidney Int. 2002;62:1933–1946.
   PubMed Web of Science ®Google Scholar
• Germain DP, Waldek S, Banikazemi M, et al. Sustained, long-term renal stabilization after 54 months of agalsidase β therapy in patients with Fabry disease. J Am Soc Nephrol. 2007;18:1547–1557.
   PubMed Web of Science ®Google Scholar